Ad

Duke Street snaps up DCC's generic drugs arm

The former owner of Wagamama is close to clinching a deal to buy the generic drugs arm of DCC, a FTSE-100 conglomerate with operations spanning oil, retail and healthcare.

Previous Post Next Post